Michael Kahle

897 total citations
29 papers, 588 citations indexed

About

Michael Kahle is a scholar working on Molecular Biology, Cancer Research and Cell Biology. According to data from OpenAlex, Michael Kahle has authored 29 papers receiving a total of 588 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 9 papers in Cancer Research and 8 papers in Cell Biology. Recurrent topics in Michael Kahle's work include Cancer Genomics and Diagnostics (9 papers), Cell Adhesion Molecules Research (5 papers) and Proteoglycans and glycosaminoglycans research (4 papers). Michael Kahle is often cited by papers focused on Cancer Genomics and Diagnostics (9 papers), Cell Adhesion Molecules Research (5 papers) and Proteoglycans and glycosaminoglycans research (4 papers). Michael Kahle collaborates with scholars based in United States, Germany and Switzerland. Michael Kahle's co-authors include Gregory Bix, Jill Roberts, Funda Meric‐Bernstam, Amber M. Johnson, Boyeon Lee, Abraham Al Ahmad, Lisa D. Auckland, Christi Parham, Apostolia M. Tsimberidou and Mehmet A. Baysal and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Michael Kahle

28 papers receiving 583 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Kahle United States 14 208 140 129 121 78 29 588
Paul McGuire United States 18 580 2.8× 180 1.3× 186 1.4× 63 0.5× 59 0.8× 27 1.6k
Yun Hyun Huh South Korea 17 350 1.7× 191 1.4× 55 0.4× 75 0.6× 51 0.7× 29 705
Michael Broman United States 18 615 3.0× 113 0.8× 94 0.7× 231 1.9× 139 1.8× 34 1.3k
Alejandra Valdivia United States 16 297 1.4× 64 0.5× 53 0.4× 153 1.3× 117 1.5× 21 596
Pengfei Lin China 19 445 2.1× 142 1.0× 64 0.5× 105 0.9× 92 1.2× 66 872
Stephanie Hung United States 8 225 1.1× 137 1.0× 315 2.4× 64 0.5× 116 1.5× 10 670
Anca Tirniceriu Germany 6 250 1.2× 38 0.3× 136 1.1× 61 0.5× 65 0.8× 6 630
Sripriya Ranganathan United States 10 455 2.2× 205 1.5× 56 0.4× 233 1.9× 108 1.4× 13 945
Vivian Tseveleki Greece 14 339 1.6× 114 0.8× 177 1.4× 24 0.2× 56 0.7× 19 855
Scott A. Coats United States 10 428 2.1× 206 1.5× 45 0.3× 78 0.6× 99 1.3× 11 956

Countries citing papers authored by Michael Kahle

Since Specialization
Citations

This map shows the geographic impact of Michael Kahle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Kahle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Kahle more than expected).

Fields of papers citing papers by Michael Kahle

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Kahle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Kahle. The network helps show where Michael Kahle may publish in the future.

Co-authorship network of co-authors of Michael Kahle

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Kahle. A scholar is included among the top collaborators of Michael Kahle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Kahle. Michael Kahle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Song, I-Wen, Henry Hiep Vo, Mehmet A. Baysal, et al.. (2023). Precision Oncology: Evolving Clinical Trials across Tumor Types. Cancers. 15(7). 1967–1967. 20 indexed citations
2.
Johnson, Amber M., Patrick Kwok‐Shing Ng, Michael Kahle, et al.. (2023). Actionability classification of variants of unknown significance correlates with functional effect. npj Precision Oncology. 7(1). 67–67. 6 indexed citations
3.
DiPeri, Timothy P., Ming Zhao, Kurt W. Evans, et al.. (2023). Convergent MAPK pathway alterations mediate acquired resistance to FGFR inhibitors in FGFR2 fusion-positive cholangiocarcinoma. Journal of Hepatology. 80(2). 322–334. 18 indexed citations
4.
Tsimberidou, Apostolia M., Michael Kahle, Henry Hiep Vo, et al.. (2023). Molecular tumour boards — current and future considerations for precision oncology. Nature Reviews Clinical Oncology. 20(12). 843–863. 54 indexed citations
5.
DiPeri, Timothy P., Kurt W. Evans, Maria Gabriela Raso, et al.. (2023). Adavosertib Enhances Antitumor Activity of Trastuzumab Deruxtecan in HER2-Expressing Cancers. Clinical Cancer Research. 29(21). 4385–4398. 17 indexed citations
6.
DiPeri, Timothy P., Ming Zhao, Michael Kahle, et al.. (2022). Abstract 2618: Convergent MAPK pathway alterations mediate acquired resistance to FGFR inhibitors in cholangiocarcinoma with FGFR fusions/rearrangements. Cancer Research. 82(12_Supplement). 2618–2618. 1 indexed citations
7.
Trout, Amanda L., Michael Kahle, Jill Roberts, et al.. (2020). Perlecan Domain-V Enhances Neurogenic Brain Repair After Stroke in Mice. Translational Stroke Research. 12(1). 72–86. 22 indexed citations
8.
Sánchez, Nora, Michael Kahle, Ann M. Bailey, et al.. (2019). Identification of Actionable Genomic Alterations Using Circulating Cell-Free DNA. JCO Precision Oncology. 3(3). 1–10. 8 indexed citations
9.
Zeng, Jia, Amber M. Johnson, Md Abu Shufean, et al.. (2019). Operationalization of Next-Generation Sequencing and Decision Support for Precision Oncology. JCO Clinical Cancer Informatics. 3(3). 1–12. 23 indexed citations
10.
Moss, Tyler J., Jordi Rodón, Holly D. Oakley, et al.. (2019). Baseline cfDNA characteristics and evolution of cfDNA profile during treatment with selective FGFR inhibitor TAS-120.. Journal of Clinical Oncology. 37(15_suppl). 3056–3056. 6 indexed citations
11.
Kahle, Michael & Bruce D. Cuevas. (2015). Interaction with the Paxillin LD1 Motif Relieves MEKK2 Auto-inhibition. PubMed. 10. 4–4. 2 indexed citations
12.
Mirza, Ahmed A., Michael Kahle, Magdalene Ameka, Edward M. Campbell, & Bruce D. Cuevas. (2014). MEKK2 regulates focal adhesion stability and motility in invasive breast cancer cells. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1843(5). 945–954. 21 indexed citations
13.
Ameka, Magdalene, Michael Kahle, Mathew Perez‐Neut, et al.. (2014). MEKK2 regulates paxillin ubiquitylation and localization in MDA-MB 231 breast cancer cells. Biochemical Journal. 464(1). 99–108. 9 indexed citations
14.
Kahle, Michael & Gregory Bix. (2013). Neuronal Restoration Following Ischemic Stroke. Neurorehabilitation and neural repair. 27(5). 469–478. 39 indexed citations
15.
Ahmad, Abraham Al, Boyeon Lee, Christi Parham, et al.. (2012). Perlecan Domain V Induces VEGf Secretion in Brain Endothelial Cells through Integrin α5β1 and ERK-Dependent Signaling Pathways. PLoS ONE. 7(9). e45257–e45257. 47 indexed citations
16.
Roberts, Jill, Michael Kahle, & Gregory Bix. (2012). Perlecan and the Blood-Brain Barrier: Beneficial Proteolysis?. Frontiers in Pharmacology. 3. 155–155. 51 indexed citations
17.
Kahle, Michael, Boyeon Lee, Tony Pourmohamad, et al.. (2012). Perlecan domain V is upregulated in human brain arteriovenous malformation and could mediate the vascular endothelial growth factor effect in lesional tissue. Neuroreport. 23(10). 627–630. 13 indexed citations
18.
Lee, Boyeon, Abraham Al Ahmad, Michael Kahle, et al.. (2011). Perlecan domain V is neuroprotective and proangiogenic following ischemic stroke in rodents. Journal of Clinical Investigation. 121(8). 3005–3023. 121 indexed citations
19.
Kahle, Michael, et al.. (1991). Effects of positive end-expiratory pressure (PEEP) ventilation on the exocrine pancreas in minipigs. Research in Experimental Medicine. 191(1). 309–325. 4 indexed citations
20.
Kahle, Michael, et al.. (1989). Lysolecithin concentration in pancreatic tissue during therapy with phospholipase A2-inhibitors in acute necrotizing pancreatitis. Journal of Molecular Medicine. 67(3). 177–179. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Paul McGuire Breakdown of academic impact, for papers by Yun Hyun Huh Breakdown of academic impact, for papers by Michael Broman Breakdown of academic impact, for papers by Alejandra Valdivia Breakdown of academic impact, for papers by Pengfei Lin Breakdown of academic impact, for papers by Stephanie Hung Breakdown of academic impact, for papers by Anca Tirniceriu Breakdown of academic impact, for papers by Sripriya Ranganathan Breakdown of academic impact, for papers by Vivian Tseveleki Breakdown of academic impact, for papers by Scott A. Coats
Rankless by CCL
2026